Chad Patterson Sells 2,555 Shares of iRhythm Technologies Inc, Modestly Overvalued According to GF Value

Chad Patterson, Chief Commercial Officer at iRhythm Technologies Inc, sold 2,555 shares of the company on August 6, 2025, according to a SEC filing. Following this transaction, Patterson now owns 43,667 shares of iRhythm Technologies Inc. The company specializes in cardiac monitoring and has seen more insider selling than buying over the past year. Patterson has sold a total of 28,761 shares and has not purchased any shares.

Chad Patterson, Chief Commercial Officer at iRhythm Technologies Inc., sold 2,555 shares of the company on August 6, 2025, according to a SEC filing. Following this transaction, Patterson now owns 43,667 shares of iRhythm Technologies Inc. The company specializes in cardiac monitoring and has seen more insider selling than buying over the past year. Patterson has sold a total of 28,761 shares and has not purchased any shares [1].

iRhythm Technologies Inc. reported a quarterly revenue increase of 26.1%, reaching $186.69 million, and earnings per share of ($0.32), surpassing analyst expectations. The stock's current price is $160.99, with a market cap of $5.17 billion, and analysts maintain a consensus rating of "Moderate Buy" with a price target of $157.30 [1].

Analysts have shown a strong buy consensus for iRhythm Technologies Inc., with Truist Financial analyst Richard Newitter maintaining a Buy rating with a price target of $175.00. The company's market cap is $5.3B and has a P/E ratio of -56.19. However, corporate insider activity shows negative sentiment with an increase in insiders selling shares over the past quarter [2].

Despite the strong analyst sentiment and the company's impressive Q2 2025 performance, the negative insider activity may indicate concerns about the company's long-term trajectory. Investors should be mindful of this and consider the longer-term outlook of the business.

References:
[1] https://www.marketbeat.com/instant-alerts/irhythm-technologies-nasdaqirtc-insider-chad-patterson-sells-2555-shares-2025-08-07/
[2] https://www.ainvest.com/news/truist-financial-reiterates-buy-rating-irhythm-technologies-175-price-target-2508/